application
application

- The call for the 11 PhD positions (description of projects below) is closed -

The selection committee is currently handling all applications. Applicants will be notified by the end of November, whether they have been selected for the interviews in Innsbruck. The interviews will be in the beginning of January 2020. CORVOS will reimburse the travel expenses for the selected candidates.

 

Why CORVOS?

The Marie Sklodowska-Curie project CORVOS is funded as an Innovative Training Network (ITN) – European Joint Doctorate (EJD). To keep it simple, one can say that CORVOS is an European-wide doctoral programme. Its focus lies on education of early stage researchers (ESRs) in the field of complement in opportunistic infections. This interdisciplinary doctoral programme is supported by 10 European universities, 2 research institutes, 3 biomedical companies and 3 hospitals, as explained here. The ESRs will have enhanced career perspectives in the academic and non-academic sectors through international, interdisciplinary and inter-sectoral mobility combined with an innovation-oriented mind-set.

  • Individual supervision & monitoring (individual thesis steering committee)
  • A highly structured, international CORVOS-specific educational programme
  • A one-month industrial training in one of our biomedical partner companies
  • A one-month clinical training in one of our partner hospitals
  • Funded 6-months research exchange to a European partner university of CORVOS
  • A "double" PhD degree issued by your main university and the partner university you will visit for 6 months
  • Annual meetings with other Marie Curie fellows of CORVOS
  • Interaction with other European doctoral programmes, such as HOROS or IRTG1911
  • You will build up a very attractive professional network for your future
  • State of the art facilities and resources
  • Very competitive salary, that is higher than average for a PhD position in the respective country 
  • A mobility allowance of 600€/month on top of the salary, that will be added automatically 
  • A family allowance of 500€/month on top of the salary, if married or in a registered relationship

 

Join CORVOS: Requirements

We are looking for highly qualified and motivated aspiring PhD students from any nationality with an open-minded and very enterprising personality, capable of working in collaborative and integrated research groups. Ideal candidates should possess a good scientific drive and a strong motivation to succeed.

  • You have a full study completing degree (Master, Magister, Diploma, MD) in medicinenatural sciences or related disciplines until March 2020
  • You are an Early Stage Researcher (ESR) – you either just finished your studies, or you have worked less than 4 years as an employee in the biomedical sector after obtaining your degree
  • You have to show academic excellence, scientific potential, flexibility, motivation and suitability for the research project
  • You have the willingness to stay abroad for 3 years from your current residence and willingness to travel through Europe
  • You comply with the mobility rule for Marie Sklodowska Curie ITN fellows – Researchers must not have resided or carried out their main activity (work, studies, etc.) in the country of the recruiting university for more than 12 months in the 3 years immediately before the recruitment date. This will be thouroughly checked.

If you are fascinated by the CORVOS programme & meet the requirements, please apply as described below for up to two of the following projects:

Project AT-1 
Generation, characterisation and commercialisation of native-restricted and neoepitope-specific monoclonal antibodies directed against the terminal complement protein C7

Your main university will be Medical University of Innsbruck (Austria). You will have a 6-months research secondment at Semmelweis University (Budapest, Hungary), where you continue to scientifically work on your thesis project. You will have a further 6-months research secondment at Hycult Biotech (Uden, Netherlands) where you will develop commercial assays. You will have a 1-month clinical training at University Hospital Helsinki (Finland) and you will have a 1-month entrepreneur training at Hycult Biotech. Finally, you will receive a PhD issued by Medical University of Innsbruck and Semmelweis University if you fulfil the respective requirements.
Please read the full project description in this PDF.


Project AT-2
Influence of HIV-1 opsonization on APC functions with regard to persistence of the virus and opportunistic pathogens, such as Mycobacteria spp. within relevant human 3D models

Your main university will be Medical University of Innsbruck (Austria). You will have a 6-months research secondment at University of Lübeck/Research Center Borstel (Germany), where you continue to scientifically work on your thesis project. You will have a 1-month clinical training at University Hospital Helsinki (Finland) and you will have a 1-month entrepreneur training at Research Center Borstel. Finally, you will receive a PhD issued by Medical University of Innsbruck and University of Lübeck if you fulfil the respective requirements.
Please read the full project description in this PDF.


Project DE-1

Characterization of C5aR2 expression and function in Toxoplasma gondii infection

Your main university will be University of Lübeck (Germany). You will have a 6-months research secondment at Medical University of Innsbruck (Austria), where you continue to scientifically work on your thesis project. You will have a further 6-months research secondment at Hycult Biotech (Uden, Netherlands) where you will generate and characterize C5aR2-specific mAbs. You will have a 1-month clinical training at University Hospital Helsinki (Finland) and you will have a 1-month entrepreneur training at Hycult Biotech. Finally, you will receive a PhD issued by University of Lübeck and Medical University of Innsbruck if you fulfil the respective requirements.
Please read the full project description in this PDF.


Project DE-2
The impact of the MBL pathway on the outcome of infection with representative mycobacterial strains of the Mycobacterium tuberculosis complex

Your main university will be University of Lübeck (Germany). However, you will mainly work at RCB in Borstel (Germany). You will have a 6-months research secondment at University of Copenhagen (Denmark), where you continue to scientifically work on your thesis project. You will have a further 6-months research secondment at RCB (Germany) where you will investigate the impact of MBL on the course of experimental tuberculosis. You will have a 1-month clinical training at University Hospital Helsinki (Finland) and you will have a 1-month entrepreneur training at RCB. Finally, you will receive a PhD issued by University of Lübeck and University of Copenhagen if you fulfil the respective requirements.
Please read the full project description in this PDF.

Project IT-1
Role of pentraxin and interaction with complement in immune defence against opportunistic infections

Your main university will be Humanitas University Milano (Italy). You will have a 6-months research secondment at University of Helsinki (Finland), where you continue to scientifically work on your thesis project. You will have a 1-month clinical training at Research Center Borstel Hospital (Germany) and you will have a 1-month entrepreneur training at MSD Finland (Helsinki). Finally, you will receive a PhD issued by Humanitas University and Helsingin Yliopisto (FI) if you fulfil the respective requirements. 
Please read the full project description in this PDF.

Project SE-1
Identification of novel complement evasion mechanisms developed by bacterial pathogens 

Your main university will be Lund University (Sweden). You will have a 6-months research secondment at Utrecht University/ University Medical Center Utrecht (Netherlands), where you continue to scientifically work on your thesis project. You will have a 1-month clinical training at Research Center Borstel Hospital (Borstel, Germany) and you will have a 1-month entrepreneur training at MSD Finland (Helsinki). Finally, you will receive a PhD issued by Lund University and Utrecht University if you fulfil the respective requirements.
Please read the full project description in this PDF.

Project NL-1
Complement resistance mechanisms by multi-drug resistant Klebsiella pneumonia

Your main university will be Utrecht University/ University Medical Center Utrecht (Netherlands). You will have a 6-months research secondment at Lund University (Sweden), where you continue to scientifically work on your thesis project. You will have a 1-month clinical training at Tirol Kliniken Innsbruck (Austria) and a 1-month entrepreneur training at Statens Serum Institut (Copenhagen, Denmark). Finally, you will receive a PhD issued by Utrecht University and Lund University if you fulfil the respective requirements.
Please read the full project description in this PDF.

Project FI-1
FH, FHR and PTX-3 binding to opportunistic bacteria and malaria parasites 

Your main university will be University of Helsinki (Finland). You will have a 6-months research secondment at Humanitas University Milano (Italy), where you continue to scientifically work on your thesis project. You will have a further 6-months research secondment at MSD Finland (Helsinki) where you will learn industrial approaches to vaccine research. You will have a 1-month clinical training at Tirol Kliniken Innsbruck (Austria) and a 1-month entrepreneur training at MSD Finland (Helsinki). Finally, you will receive a PhD issued by University of Helsinki and Humanitas University Milano if you fulfil the respective requirements.
Please read the full project description in this PDF.

Project DK-1
Evaluation of fungal complement evasion mechanisms via the lectin pathway

Your main university will be University of Copenhagen (Denmark). You will have a 6-months research secondment at University of Lübeck (Germany), where you continue to scientifically work on your thesis project. You will have a further 6-months research secondment at Statens Serum Institut (Copenhagen, Denmark) where you will do experiments with opportunistic bacteria. You will have a 1-month clinical training at Tirol Kliniken (Innsbruck, Austria) and a 1-month entrepreneur training at Statens Serum Institut. Finally, you will receive a PhD issued by University of Copenhagen and University of Lübeck if you fulfil the respective requirements.
Please read the full project description in this PDF.

Project NO-2
Single and double inhibition of complement and CD14 in opportunistic conditions

Your main university will be University of Oslo (Norway). You will have a 6-months research secondment at Medical University of Innsbruck (Austria), where you continue to scientifically work on your thesis project. You will have a further 6-months research secondment at SVAR LifeSciences (Malmö, Sweden) where you will develop a new complement activation assay, based on the mab bH6, detecting a neoepitope exposed on C3 fragments. You will have a 1-month clinical training at Research Center Borstel Hospital (Borstel, Germany) and a 1-month entrepreneur training at SVAR LifeSciences. Finally, you will receive a PhD issued by University of Oslo and Medical University of Innsbruck if you fulfil the respective requirements.
Please read the full project description in this PDF.

Project HU-1
Development of immunoassays for specific classical and lectin pathway activation markers

Your main university will be Semmelweis University (Budapest, Hungary). You will have a 6-months research secondment at Medical University of Innsbruck (Austria), where you continue to scientifically work on your thesis project. You will have a further 6-months research secondment at Hycult Biotech (Uden, Netherlands) where you will develop commercial assays using generated mAbs. You will have a 1-month clinical training at Research Center Borstel Hospital (Borstel, Germany) and you will have a 1-month entrepreneur training at Hycult Biotech. Finally, you will receive a PhD issued by Semmelweis University and Medical University of Innsbruck if you fulfil the respective requirements.
Please read the full project description in this PDF.


Of note: Four more positions will be advertised from March 2020. These projects will be supervised by Veronique Fremeaux-Bacchi (FR-1), Seppo Meri (FI-2), Peter Garred (DK-2), Tom Eirik Mollnes (NO-1). 

 

Application

Please submit the following documents compiled to ONE pdf-document by email 
(using "lastname_firstname.pdf") to corvos.application@gmail.com until 10th November 2019.

  • CV 
  • Filled application form 
  • Scan of Master/MD/Diploma document
  • Abstract of Master/MD/Diploma thesis

We can only accept complete applications. Incomplete applications will not be considered!
Please, submit just ONE pdf-document!


PhD students are selected on the basis of their application materials and the selected candidates will be invited to a personal interview to Innsbruck. The interviews will be on 03./04.01.2020 or 09.01.2020.

 

Selection process

  • Verification that the application is complete and that the applicant fulfils all requirements
  • Obtaining candidate evaluations from referees
  • Evaluation by CORVOS faculty members and ranking of candidates based on their qualifications, research experience, and future plans
  • Invitation of preselected candidates for a hearing and personal job interview in Innsbruck on 03./04.01.2020 or 09.01.2020 (justifiable expenses for economy travelwill be reimbursed; accommodation will be arranged by us)
  • Final selection of stipendiates
  • Start of project in March 2020
Important Information

Call is closed. Applicants will be notified by the end of November for the next steps.

contact

Marco Grasse, Ph.D.
Medical University Innsbruck
Schöpfstraße 41
A-6020 Innsbruck

E-Mail:

corvos.application@gmail.com 

application

- The call for the 11 PhD positions (description of projects below) is closed -

The selection committee is currently handling all applications. Applicants will be notified by the end of November, whether they have been selected for the interviews in Innsbruck. The interviews will be in the beginning of January 2020. CORVOS will reimburse the travel expenses for the selected candidates.

 

Why CORVOS?

The Marie Sklodowska-Curie project CORVOS is funded as an Innovative Training Network (ITN) – European Joint Doctorate (EJD). To keep it simple, one can say that CORVOS is an European-wide doctoral programme. Its focus lies on education of early stage researchers (ESRs) in the field of complement in opportunistic infections. This interdisciplinary doctoral programme is supported by 10 European universities, 2 research institutes, 3 biomedical companies and 3 hospitals, as explained here. The ESRs will have enhanced career perspectives in the academic and non-academic sectors through international, interdisciplinary and inter-sectoral mobility combined with an innovation-oriented mind-set.

  • Individual supervision & monitoring (individual thesis steering committee)
  • A highly structured, international CORVOS-specific educational programme
  • A one-month industrial training in one of our biomedical partner companies
  • A one-month clinical training in one of our partner hospitals
  • Funded 6-months research exchange to a European partner university of CORVOS
  • A "double" PhD degree issued by your main university and the partner university you will visit for 6 months
  • Annual meetings with other Marie Curie fellows of CORVOS
  • Interaction with other European doctoral programmes, such as HOROS or IRTG1911
  • You will build up a very attractive professional network for your future
  • State of the art facilities and resources
  • Very competitive salary, that is higher than average for a PhD position in the respective country 
  • A mobility allowance of 600€/month on top of the salary, that will be added automatically 
  • A family allowance of 500€/month on top of the salary, if married or in a registered relationship

 

Join CORVOS: Requirements

We are looking for highly qualified and motivated aspiring PhD students from any nationality with an open-minded and very enterprising personality, capable of working in collaborative and integrated research groups. Ideal candidates should possess a good scientific drive and a strong motivation to succeed.

  • You have a full study completing degree (Master, Magister, Diploma, MD) in medicinenatural sciences or related disciplines until March 2020
  • You are an Early Stage Researcher (ESR) – you either just finished your studies, or you have worked less than 4 years as an employee in the biomedical sector after obtaining your degree
  • You have to show academic excellence, scientific potential, flexibility, motivation and suitability for the research project
  • You have the willingness to stay abroad for 3 years from your current residence and willingness to travel through Europe
  • You comply with the mobility rule for Marie Sklodowska Curie ITN fellows – Researchers must not have resided or carried out their main activity (work, studies, etc.) in the country of the recruiting university for more than 12 months in the 3 years immediately before the recruitment date. This will be thouroughly checked.

If you are fascinated by the CORVOS programme & meet the requirements, please apply as described below for up to two of the following projects:

Project AT-1 
Generation, characterisation and commercialisation of native-restricted and neoepitope-specific monoclonal antibodies directed against the terminal complement protein C7

Your main university will be Medical University of Innsbruck (Austria). You will have a 6-months research secondment at Semmelweis University (Budapest, Hungary), where you continue to scientifically work on your thesis project. You will have a further 6-months research secondment at Hycult Biotech (Uden, Netherlands) where you will develop commercial assays. You will have a 1-month clinical training at University Hospital Helsinki (Finland) and you will have a 1-month entrepreneur training at Hycult Biotech. Finally, you will receive a PhD issued by Medical University of Innsbruck and Semmelweis University if you fulfil the respective requirements.
Please read the full project description in this PDF.


Project AT-2
Influence of HIV-1 opsonization on APC functions with regard to persistence of the virus and opportunistic pathogens, such as Mycobacteria spp. within relevant human 3D models

Your main university will be Medical University of Innsbruck (Austria). You will have a 6-months research secondment at University of Lübeck/Research Center Borstel (Germany), where you continue to scientifically work on your thesis project. You will have a 1-month clinical training at University Hospital Helsinki (Finland) and you will have a 1-month entrepreneur training at Research Center Borstel. Finally, you will receive a PhD issued by Medical University of Innsbruck and University of Lübeck if you fulfil the respective requirements.
Please read the full project description in this PDF.


Project DE-1

Characterization of C5aR2 expression and function in Toxoplasma gondii infection

Your main university will be University of Lübeck (Germany). You will have a 6-months research secondment at Medical University of Innsbruck (Austria), where you continue to scientifically work on your thesis project. You will have a further 6-months research secondment at Hycult Biotech (Uden, Netherlands) where you will generate and characterize C5aR2-specific mAbs. You will have a 1-month clinical training at University Hospital Helsinki (Finland) and you will have a 1-month entrepreneur training at Hycult Biotech. Finally, you will receive a PhD issued by University of Lübeck and Medical University of Innsbruck if you fulfil the respective requirements.
Please read the full project description in this PDF.


Project DE-2
The impact of the MBL pathway on the outcome of infection with representative mycobacterial strains of the Mycobacterium tuberculosis complex

Your main university will be University of Lübeck (Germany). However, you will mainly work at RCB in Borstel (Germany). You will have a 6-months research secondment at University of Copenhagen (Denmark), where you continue to scientifically work on your thesis project. You will have a further 6-months research secondment at RCB (Germany) where you will investigate the impact of MBL on the course of experimental tuberculosis. You will have a 1-month clinical training at University Hospital Helsinki (Finland) and you will have a 1-month entrepreneur training at RCB. Finally, you will receive a PhD issued by University of Lübeck and University of Copenhagen if you fulfil the respective requirements.
Please read the full project description in this PDF.

Project IT-1
Role of pentraxin and interaction with complement in immune defence against opportunistic infections

Your main university will be Humanitas University Milano (Italy). You will have a 6-months research secondment at University of Helsinki (Finland), where you continue to scientifically work on your thesis project. You will have a 1-month clinical training at Research Center Borstel Hospital (Germany) and you will have a 1-month entrepreneur training at MSD Finland (Helsinki). Finally, you will receive a PhD issued by Humanitas University and Helsingin Yliopisto (FI) if you fulfil the respective requirements. 
Please read the full project description in this PDF.

Project SE-1
Identification of novel complement evasion mechanisms developed by bacterial pathogens 

Your main university will be Lund University (Sweden). You will have a 6-months research secondment at Utrecht University/ University Medical Center Utrecht (Netherlands), where you continue to scientifically work on your thesis project. You will have a 1-month clinical training at Research Center Borstel Hospital (Borstel, Germany) and you will have a 1-month entrepreneur training at MSD Finland (Helsinki). Finally, you will receive a PhD issued by Lund University and Utrecht University if you fulfil the respective requirements.
Please read the full project description in this PDF.

Project NL-1
Complement resistance mechanisms by multi-drug resistant Klebsiella pneumonia

Your main university will be Utrecht University/ University Medical Center Utrecht (Netherlands). You will have a 6-months research secondment at Lund University (Sweden), where you continue to scientifically work on your thesis project. You will have a 1-month clinical training at Tirol Kliniken Innsbruck (Austria) and a 1-month entrepreneur training at Statens Serum Institut (Copenhagen, Denmark). Finally, you will receive a PhD issued by Utrecht University and Lund University if you fulfil the respective requirements.
Please read the full project description in this PDF.

Project FI-1
FH, FHR and PTX-3 binding to opportunistic bacteria and malaria parasites 

Your main university will be University of Helsinki (Finland). You will have a 6-months research secondment at Humanitas University Milano (Italy), where you continue to scientifically work on your thesis project. You will have a further 6-months research secondment at MSD Finland (Helsinki) where you will learn industrial approaches to vaccine research. You will have a 1-month clinical training at Tirol Kliniken Innsbruck (Austria) and a 1-month entrepreneur training at MSD Finland (Helsinki). Finally, you will receive a PhD issued by University of Helsinki and Humanitas University Milano if you fulfil the respective requirements.
Please read the full project description in this PDF.

Project DK-1
Evaluation of fungal complement evasion mechanisms via the lectin pathway

Your main university will be University of Copenhagen (Denmark). You will have a 6-months research secondment at University of Lübeck (Germany), where you continue to scientifically work on your thesis project. You will have a further 6-months research secondment at Statens Serum Institut (Copenhagen, Denmark) where you will do experiments with opportunistic bacteria. You will have a 1-month clinical training at Tirol Kliniken (Innsbruck, Austria) and a 1-month entrepreneur training at Statens Serum Institut. Finally, you will receive a PhD issued by University of Copenhagen and University of Lübeck if you fulfil the respective requirements.
Please read the full project description in this PDF.

Project NO-2
Single and double inhibition of complement and CD14 in opportunistic conditions

Your main university will be University of Oslo (Norway). You will have a 6-months research secondment at Medical University of Innsbruck (Austria), where you continue to scientifically work on your thesis project. You will have a further 6-months research secondment at SVAR LifeSciences (Malmö, Sweden) where you will develop a new complement activation assay, based on the mab bH6, detecting a neoepitope exposed on C3 fragments. You will have a 1-month clinical training at Research Center Borstel Hospital (Borstel, Germany) and a 1-month entrepreneur training at SVAR LifeSciences. Finally, you will receive a PhD issued by University of Oslo and Medical University of Innsbruck if you fulfil the respective requirements.
Please read the full project description in this PDF.

Project HU-1
Development of immunoassays for specific classical and lectin pathway activation markers

Your main university will be Semmelweis University (Budapest, Hungary). You will have a 6-months research secondment at Medical University of Innsbruck (Austria), where you continue to scientifically work on your thesis project. You will have a further 6-months research secondment at Hycult Biotech (Uden, Netherlands) where you will develop commercial assays using generated mAbs. You will have a 1-month clinical training at Research Center Borstel Hospital (Borstel, Germany) and you will have a 1-month entrepreneur training at Hycult Biotech. Finally, you will receive a PhD issued by Semmelweis University and Medical University of Innsbruck if you fulfil the respective requirements.
Please read the full project description in this PDF.


Of note: Four more positions will be advertised from March 2020. These projects will be supervised by Veronique Fremeaux-Bacchi (FR-1), Seppo Meri (FI-2), Peter Garred (DK-2), Tom Eirik Mollnes (NO-1). 

 

Application

Please submit the following documents compiled to ONE pdf-document by email 
(using "lastname_firstname.pdf") to corvos.application@gmail.com until 10th November 2019.

  • CV 
  • Filled application form 
  • Scan of Master/MD/Diploma document
  • Abstract of Master/MD/Diploma thesis

We can only accept complete applications. Incomplete applications will not be considered!
Please, submit just ONE pdf-document!


PhD students are selected on the basis of their application materials and the selected candidates will be invited to a personal interview to Innsbruck. The interviews will be on 03./04.01.2020 or 09.01.2020.

 

Selection process

  • Verification that the application is complete and that the applicant fulfils all requirements
  • Obtaining candidate evaluations from referees
  • Evaluation by CORVOS faculty members and ranking of candidates based on their qualifications, research experience, and future plans
  • Invitation of preselected candidates for a hearing and personal job interview in Innsbruck on 03./04.01.2020 or 09.01.2020 (justifiable expenses for economy travelwill be reimbursed; accommodation will be arranged by us)
  • Final selection of stipendiates
  • Start of project in March 2020

Important Information

Call is closed. Applicants will be notified by the end of November for the next steps.


contact

Marco Grasse, Ph.D.
Medical University Innsbruck
Schöpfstraße 41
A-6020 Innsbruck

E-Mail:

corvos.application@gmail.com 



contact

PROGRAMME SPEAKER

Reinhard Würzner, MD PhD
Schöpfstraße 41
A-6020 Innsbruck

Imprint

Partner

HORIZON 2020 MSCA – ITN – EJD 860044